Market growth is fueled by an increasing prevalence of skin conditions, including acne, psoriasis, and skin cancer, alongside a broader societal shift toward minimally invasive rejuvenation treatments. As disposable incomes rise and the global population ages, clinics and aesthetic centers are reporting higher patient volumes, necessitating more precise diagnostic and therapeutic tools. Laser-based technologies currently dominate the landscape, holding a 37.4% market share as of 2025 due to their versatility in hair removal, scar revision, and lesion treatment.
Dermatology Device Market Projected to Reach $17.73 Billion by 2031
The global dermatology devices market is set for significant expansion, with projections indicating a valuation of $17.73 billion by 2031. Driven by a 13.7% compound annual growth rate from its 2026 baseline of $9.32 billion, the sector is capitalizing on a rising demand for both medical and aesthetic skin procedures.
North America remains the primary regional hub, bolstered by established healthcare infrastructure and high patient awareness. While major industry players like Bausch Health, AbbVie, and InMode maintain strong market positions, specialized startups are increasingly carving out niches through innovations in high-resolution imaging and radiofrequency devices. This technological evolution, integrating modalities such as optical coherence tomography, is effectively reducing the reliance on invasive diagnostic methods, further accelerating adoption across hospitals and specialized dermatology clinics.
Comments (0)
No comments yet. Be the first!